GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research.

Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, Altman DG, Moher D, Barber R, Denegri S, Entwistle A, Littlejohns P, Morris C, Suleman R, Thomas V, Tysall C. · 2017

Read GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. by Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, Altman DG, Moher D, Barber R, Denegri S, Entwistle A, Littlejohns P, Morris C, Suleman R, Thomas V, Tysall C. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5611595.txt.

Introduction

Staniszewska and co-authors present the GRIPP2 reporting checklists in Research Involvement and Engagement. Patients and the public now join research teams often. Papers report that involvement poorly and unevenly. Readers cannot tell how it worked, or for whom.

The team built consensus guidance the EQUATOR way. An updated review refreshed the original GRIPP checklist. A three-round Delphi survey gathered expert views. One hundred forty-three people joined the first round. A face-to-face meeting settled the open items. Patients served as partners through the whole build. Two checklists came out of the process. The long form holds 34 items for studies focused on involvement. The short form holds five for studies where involvement is secondary. Readers get the first international, evidence-based standard for reporting public involvement.

Catalog record

CREATORStaniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, Altman DG, Moher D, Barber R, Denegri S, Entwistle A, Littlejohns P, Morris C, Suleman R, Thomas V, Tysall C.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE27 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5611595

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research By S Staniszewska, J Brett, I Simera, K Seers, C Mockford, S Goodlad, D G Altman, D Moher, R Barber, S Denegri, A Entwistle, P Littlejohns Published in: Research Involvement and Engagement DOI: 10.1186/s40900-017-0062-2 ABSTRACT Abstract Background While the patient and public involvement (PPI) evidence base has expanded over the past decade, the quality of reporting within papers is often inconsistent, limiting our understanding of how it works, in what context, for whom, and why. Objective To develop international consensus on the key items to report to enhance the quality, transparency, and consistency of the PPI evidence base. To collaboratively involve patients as research partners at all stages in the development of GRIPP2. Methods The EQUATOR method for developing reporting guidelines was used. The original GRIPP (Guidance for Reporting Involvement of Patients and the Public) checklist was revised, based on updated systematic review evidence. A three round Delphi survey was used to develop consensus on items to be included in the guideline. A subsequent face-to-face meeting produced agreement on items not reaching consensus during the Delphi process. Results One hundred forty-three participants agreed to participate in round one, with an 86% (123/143) response for round two and a 78% (112/143) response for round three. The Delphi survey identified the need for long form (LF) and short form (SF) versions. GRIPP2-LF includes 34 items on aims, definitions, concepts and theory, methods, stages and nature of involvement, context, capture or measurement of impact, outcomes, economic assessment, and reflections and is suitable for studies where the main focus is PPI. GRIPP2-SF includes five items on aims, methods, results, outcomes, and critical perspective and is suitable for studies where PPI is a secondary focus. Conclusions GRIPP2-LF and GRIPP2-SF represent the first international evidence based, consensus informed guidance for reporting patient and public involvement in research. Both versions of GRIPP2 aim to improve the quality, transparency, and consistency of the international PPI evidence base, to ensure PPI practice is based on the best evidence. In order to encourage its wide dissemination this article is freely accessible on The BMJ and Research Involvement and Engagement journal websites. Electronic supplementary material The online version of this article (doi:10.1186/s40900-017-0062-2) contains supplementary material, which is available to authorized users. PLAIN ENGLISH SUMMARY Patient and public involvement in health and social care research is increasingly important, helping to ensure that the research focuses on issues relevant to patients and the public. A wide variety of research papers with public involvement has been published over the past decade, yet many of these papers give little information about how members of the public were involved and what the result of this involvement was. This means that learning from these studies is limited. Working closely with patients and the public, we have developed guidance for people writing about public involvement to suggest what details to report. We carried out a thorough assessment of studies in this area and used a Delphi survey to ask 143 people who are knowledgeable about this topic for their opinions about what should be included in the guidance. The Delphi method consists of a series of questionnaires over a specific time period to find out whether there is agreement among experts about the topic under discussion. We found strong agreement on a number of issues to include in the guidance from the 112 people who completed three rounds of Delphi questionnaires. We also held a one day meeting to find out whether any additional issues for which we hadn’t reached agreement should be included in the guidance. As a result of this three stage project, we developed two versions of the guidance, a short version of the guidance (GRIPP2-SF), which can be used when reporting public involvement in any study, and a long version (GRIPP2-LF) to use when the study is mainly about public involvement in research. Our aim in developing this guidance is to promote good quality reporting of public involvement, to inform good practice and create effective public involvement. BACKGROUND The EQUATOR network has developed high standard reporting guidelines such as the CONSORT (Consolidated standards of Reporting Trials) statement and the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement enhancing the quality of research reporting, but no guidance has been developed specifically for the reporting of patient and public involvement (PPI). This prompted the development of the original Guidance for Reporting Involvement of Patients and the Public (GRIPP), which tackled inconsistent reporting by helping researchers, patients, carers, and the public to improve the quality, consistency, and transparency of PPI reporting, to strengthen the quality of the international PPI evidence base [1]. While the original GRIPP checklist represented an important starting point in creating high quality PPI reporting, its development drew on systematic review evidence, without broader input from the international PPI research community [2–4]. Achieving consensus is now acknowledged as a crucial step in producing a reporting guideline [5]. GRIPP2 tackled this gap by developing consensus in the international PPI community. INVOLVE defines public involvement in research as being carried out with or by members of the public rather than to, about, or for them. PPI in research can improve the relevance and overall quality of research, by ensuring that it focuses on the issues of importance to patients [1]. This includes, for example, working with research funders to prioritise research; the development of more patient relevant research questions, study designs, and outcomes; offering the patient perspective as members of a project steering group; commenting on and developing research materials to improve readability; assisting with recruitment to studies; lay write up of the studies; and advocacy of study results [2–4, 6–9]. In the UK, the National Institute for Health Research has provided vital strategic and infrastructure support to embed PPI across publicly funded research, creating a context where PPI is seen as a key element in research. Internationally PPI is also developing, with similar initiatives in Canada, United States, Australia, and Europe [10, 11]. Networks such as the citizen and patient involvement group of Health Technology International have evolved, enabling international collaboration in relation to involvement and engagement [12]. While the PPI evidence base has expanded significantly over the past decade, the reporting of PPI in papers has often been inconsistent and partial, with little information about the context, process, and impact of public involvement and with limited reporting of conceptualisation or theorisation [1–4]. Inadequate reporting can create problems for systematic reviews that attempt to synthesise PPI evidence [2–4]. Appraisal, interpretation, and synthesis of results are difficult, aside from the ethical imperatives of reporting research in a way that others understand and can use [13–16]. Inconsistent reporting creates a fragmented evidence base making it difficult to draw together our collective understanding of what works, for whom, why, and in what context. Furthermore, researchers, patients, carers, or clinicians cannot learn from previous experience, and precious resources devoted to involving patients and the public are wasted. Omitting descriptions of PPI activities from a study can represent a form of misreporting and might misrepresent the initial intentions of a study. This article introduces the two versions of the GRIPP2 reporting checklist: GRIPP2-LF, a

Read the complete text